- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.30 Å
- Oligo State
- hetero-1-1-3-3-3-3-mer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 4 residues within 4Å:- Chain I: Q.324, S.349, N.353
- Ligands: NAG-NAG.1
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain I: N.300, W.356
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain I: N.257, T.259, H.291, N.293, R.404
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain I: N.224, S.253, N.408
- Ligands: NAG-NAG-BMA-MAN-MAN.2
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain I: N.263, I.284, V.402
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain I: E.57, N.58
- Chain J: G.13, S.17
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain I: R.154, N.159
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain I: N.103
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain I: N.196, T.198, I.234, H.313
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain I: N.238, N.241
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain J: N.107, S.109
Ligand excluded by PLIPNAG.23: 5 residues within 4Å:- Chain K: Q.324, S.349, N.353
- Ligands: NAG-NAG.5, NAG-NAG.5
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain K: S.253, V.406, N.408
- Ligands: NAG-NAG.6
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain K: N.103, G.114
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain K: V.144, N.159, T.160
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain K: N.263, I.284, V.402
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain K: N.257, T.259, H.291, N.293, R.404
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain K: Q.255, N.257, N.293, S.295, R.404
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain K: N.238, N.241
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain K: N.196, T.198, S.236, H.313
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain K: E.57, N.58
- Chain L: G.13, S.17
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain L: N.107, S.109, E.110
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain L: N.100, S.102
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain L: E.123, N.126
Ligand excluded by PLIPNAG.36: 7 residues within 4Å:- Chain M: V.104, T.105, N.106, N.118, Y.135, L.137, D.282
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain M: N.103
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain M: T.333, T.334, N.347, S.349
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain M: S.349, N.353
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain M: N.238, T.240, N.241
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain M: N.196, T.198, S.236
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain M: N.257, T.259, H.291, N.293, R.404
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain M: N.263, I.284, V.402
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain M: Q.255, N.257, N.293, V.406
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain M: N.224, S.253, N.408
- Ligands: NAG-NAG.11
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain M: N.300, W.356
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain M: N.316
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain N: N.100, S.102
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain N: K.122, E.123, N.126
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain F: S.107
- Chain N: N.107, S.109
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ma, K.M. et al., HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates. Sci Immunol (2025)
- Release Date
- 2025-08-06
- Peptides
- RM017 Fab heavy chain: A
RM017 Fab light chain: B
RM20A3 Fab light chain: CEH
RM20A3 Fab heavy chain: DFG
Envelope glycoprotein gp120: IKM
Transmembrane protein gp41: JLN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
GE
JH
ND
IF
KG
MI
AK
CM
DJ
BL
EN
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.30 Å
- Oligo State
- hetero-1-1-3-3-3-3-mer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ma, K.M. et al., HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates. Sci Immunol (2025)
- Release Date
- 2025-08-06
- Peptides
- RM017 Fab heavy chain: A
RM017 Fab light chain: B
RM20A3 Fab light chain: CEH
RM20A3 Fab heavy chain: DFG
Envelope glycoprotein gp120: IKM
Transmembrane protein gp41: JLN - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
GE
JH
ND
IF
KG
MI
AK
CM
DJ
BL
EN
F